Hormone therapy in relation to survival from large bowel cancer

Cancer Causes and Control

Volumn 20, Issue 4, 2009, Pages 409-416

  Newcomb, Polly A ^a,b   Chia, Victoria M ^a   Hampton, John M ^b   Doria Rose, V Paul ^a,c   Trentham Dietz, Amy ^b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WISCONSIN   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Colorectal cancer; Hormone therapy; Mortality

Indexed keywords

ESTROGEN; GESTAGEN;

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER MORTALITY; CANCER REGISTRY; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; FOLLOW UP; HORMONAL THERAPY; HUMAN; INTERVIEW; LARGE INTESTINE CANCER; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

ADULT; AGED; CASE-CONTROL STUDIES; COHORT STUDIES; COLORECTAL NEOPLASMS; DEATH CERTIFICATES; ESTROGEN REPLACEMENT THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; INTERVIEWS AS TOPIC; MEDICAL RECORD LINKAGE; MIDDLE AGED; POPULATION SURVEILLANCE; PROPORTIONAL HAZARDS MODELS; QUESTIONNAIRES; REGISTRIES; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS; TIME FACTORS; WISCONSIN;

EID: 64649099894     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-008-9255-1     Document Type: Article

References (28)

1. JD Potter 1999 Colorectal cancer: molecules and populations J Natl Cancer Inst 91 916 932 10.1093/jnci/91.11.916
2. I Csizmadi JP Collet A Benedetti JF Boivin JA Hanley 2004 The effects of transdermal and oral oestrogen replacement therapy on colorectal cancer risk in postmenopausal women Br J Cancer 90 76 81 10.1038/sj.bjc.6601438
3. M Gambacciani P Monteleone A Sacco AR Genazzani 2003 Hormone replacement therapy and endometrial, ovarian and colorectal cancer Best Pract Res Clin Endocrinol Metab 17 139 147 10.1016/S1521-690X(02)00086-6
4. F Grodstein PA Newcomb MJ Stampfer 1999 Postmenopausal hormone therapy and the risk of colorectal cancer: a review and meta-analysis Am J Med 106 574 582 10.1016/S0002-9343(99)00063-7
5. R Chlebowski J Wactawski-Wende C Ritenbaugh 2004 Estrogen plus progestin and colorectal cancer in postmenopausal women N Engl J Med 350 991 1004 10.1056/NEJMoa032071
6. N Prihartono JR Palmer C Louik S Shapiro L Rosenberg 2000 A case-control study of use of postmenopausal female hormone supplements in relation to the risk of large bowel cancer Cancer Epidemiol Biomarkers Prev 9 443 447
7. JE Rossouw GL Anderson RL Prentice 2002 Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial JAMA 288 321 333 10.1001/jama.288.3.321
8. PA Newcomb BE Storer 1995 Postmenopausal hormone use and risk of large-bowel cancer J Natl Cancer Inst 87 1067 1071 10.1093/jnci/87.14.1067
9. PA Newcomb Y Zheng VM Chia 2007 Estrogen plus progestin use, microsatellite instability, and the risk of colorectal cancer in women Cancer Res 67 7534 7539 10.1158/0008-5472.CAN-06-4275
10. PT Campbell P Newcomb S Gallinger M Cotterchio JR McLaughlin 2007 Exogenous hormones and colorectal cancer risk in Canada: associations stratified by clinically defined familial risk of cancer Cancer Causes Control 18 723 733 10.1007/s10552-007-9015-7
11. M Hoffmeister E Raum J Winter J Chang-Claude H Brenner 2007 Hormone replacement therapy, body mass, and the risk of colorectal cancer among postmenopausal women from Germany Br J Cancer 97 1486 1492 10.1038/sj.bjc. 6604066
12. G Heiss R Wallace GL Anderson 2008 Health risks and benefits 3 years after stopping randomized treatment with estrogen and progestin JAMA 299 1036 1045 10.1001/jama.299.9.1036
13. MT Mandelson D Miglioretti PA Newcomb R Harrison JD Potter 2003 Hormone replacement therapy in relation to survival in women diagnosed with colon cancer Cancer Causes Control 14 979 984 10.1023/B:CACO.0000007970.04094.76
14. ML Slattery K Anderson W Samowitz 1999 Hormone replacement therapy and improved survival among postmenopausal women diagnosed with colon cancer Cancer Causes Control 10 467 473 10.1023/A:1008974215622
15. EE Calle HL Miracle-McMahill MJ Thun CW Heath Jr 1995 Estrogen replacement therapy and risk of fatal colon cancer in a prospective cohort of postmenopausal women J Natl Cancer Inst 87 517 523 10.1093/jnci/87.7.517
16. C Ritenbaugh JL Stanford L Wu 2008 Conjugated equine estrogens and colorectal cancer incidence and survival: The Women's Health Initiative Randomized Clinical Trial Cancer Epidemiol Biomarkers Prev 17 2609 2618 10.1158/1055-9965.EPI-08-0385
17. GL Anderson M Limacher AR Assaf 2004 Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial JAMA 291 1701 1712 10.1001/jama.291.14. 1701
18. AL Hersh ML Stefanick RS Stafford 2004 National use of postmenopausal hormone therapy: annual trends and response to recent evidence JAMA 291 47 53 10.1001/jama.291.1.47
19. HB Nichols A Trentham-Dietz JM Hampton PA Newcomb 2005 Oral contraceptive use, reproductive factors, and colorectal cancer risk: findings from Wisconsin Cancer Epidemiol Biomarkers Prev 14 1212 1218 10.1158/1055-9965.EPI-04-0845
20. VP Doria-Rose PA Newcomb LM Morimoto JM Hampton A Trentham-Dietz 2006 Body mass index and the risk of death following the diagnosis of colorectal cancer in postmenopausal women (United States) Cancer Causes Control 17 63 70 10.1007/s10552-005-0360-0
21. Percy C, Van Holten V, Muir C (1990) International classification of diseases for oncology, 2nd edn. World Health Organization, Geneva
22. EE Calle DD Terrell 1993 Utility of the National Death Index for ascertainment of mortality among cancer prevention study II participants Am J Epidemiol 137 235 241
23. Breslow NE, Day NE (1987) Statistical methods in cancer research. Volume II-The design and analysis of cohort studies. IARC Scientific Publications, Lyon
24. JA Chan JA Meyerhardt AT Chan 2006 Hormone replacement therapy and survival after colorectal cancer diagnosis J Clin Oncol 24 5680 5686 10.1200/JCO.2006.08.0580
25. I Persson J Yuen L Bergkvist C Schairer 1996 Cancer incidence and mortality in women receiving estrogen and estrogen-progestin replacement therapy-long-term follow-up of a Swedish cohort Int J Cancer 67 327 332 10.1002/(SICI)1097-0215(19960729)67:3<327::AID-IJC4>3.0.CO;2-T
26. SR Sturgeon C Schairer LA Brinton T Pearson RN Hoover 1995 Evidence of a healthy estrogen user survivor effect Epidemiology 6 227 231
27. SL Zielinski 2005 Hormone replacement therapy for breast cancer survivors: an answered question? J Natl Cancer Inst 97 955
28. M Campbell-Thompson IJ Lynch B Bhardwaj 2001 Expression of estrogen receptor (ER) subtypes and ERbeta isoforms in colon cancer Cancer Res 61 632 640